BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bai X, Dee R, Mangum KD, Mack CP, Taylor JM. RhoA signaling and blood pressure: The consequence of failing to “Tone it Down”. World J Hypertens 2016; 6(1): 18-35 [DOI: 10.5494/wjh.v6.i1.18]
URL: https://www.wjgnet.com/2220-3168/full/v6/i1/18.htm
Number Citing Articles
1
Amanda S. Fjorder, Malene B. Rasmussen, Mana M. Mehrjouy, Lusine Nazaryan-Petersen, Claus Hansen, Mads Bak, Niels Grarup, Anne Nørremølle, Lars A. Larsen, Henrik Vestergaard, Torben Hansen, Niels Tommerup, Iben Bache. Haploinsufficiency of ARHGAP42 is associated with hypertensionEuropean Journal of Human Genetics 2019; 27(8): 1296 doi: 10.1038/s41431-019-0382-9
2
Qifei Li, Michal Dibus, Alicia Casey, Christina S. K. Yee, Sara O. Vargas, Shiyu Luo, Samantha M. Rosen, Jill A. Madden, Casie A. Genetti, Jan Brabek, Catherine A. Brownstein, Shideh Kazerounian, Benjamin A. Raby, Klaus Schmitz-Abe, John C. Kennedy, Martha P. Fishman, Mary P. Mullen, Joan M. Taylor, Daniel Rosel, Pankaj B. Agrawal, Randy Q Cron. A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findingsPLOS Genetics 2021; 17(7): e1009639 doi: 10.1371/journal.pgen.1009639
3
Mohammadreza Shoghli, A. Inkeri Lokki, Mitja Lääperi, Juha Sinisalo, Marja-Liisa Lokki, Mika Hilvo, Antti Jylhä, Jaakko Tuomilehto, Reijo Laaksonen. The Novel Ceramide- and Phosphatidylcholine-Based Risk Score for the Prediction of New-Onset of HypertensionJournal of Clinical Medicine 2023; 12(24): 7524 doi: 10.3390/jcm12247524